MEDICAL THERAPY IN BENIGN PROSTATIC HYPERPLASIA

这项申请的资金将建立一个临床中心， “良性前列腺增生药物治疗的临床试验”， 由国家糖尿病研究所赞助的多中心试验， 消化和肾脏疾病临床试验中心，大学 位于加州圣地亚哥（UCSD）。试验的主要目的是 确定药物治疗（非那普利和/或多沙唑嗪）是否延迟或 预防BPH的进展。 如果被选为临床中心， UCSD临床试验中心将招募，筛选和进入评估 在两年的招募期内，240名合适的受试者进入研究， 并按照标准化的多中心方案完成研究。

Funding of this application will establish a Clinical Center for the "Clinical Trial of Medical Therapy in Benign Prostatic Hyperplasia", a multi-center trial sponsored by the national Institute of Diabetes and Digestive and Kidney Diseases at the Clinical Trials Center, University of California, San Diego (UCSD). The primary objective of the trial is to ascertain if medical therapy (finasteride and/or doxazosin) delays or prevents the progression of BPH. If selected as a clinical center, the UCSD Clinical Trials Center will recruit, screen and enter for evaluation 240 suitable subjects into the study over a two year enrollment period, and complete the study following the standardized multi-center protocol.